Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Summary

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Eligibility

Inclusion Criteria:

* Subject age 18 years and older
* Subject is scheduled/was scheduled for a bronchoscopy as part of standard of care
* Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
* Ability to provide blood or saliva sample
* Ability to provide archived tissue
* Subject is able to understand and adhere to study requirements and able to provide informed consent

Exclusion Criteria:

* Individuals who have situations that would limit compliance with the study requirements
* Institutionalized (i.e. federal medical prison)
* Pregnant
* Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment
* Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment

Conditions4

Locations1 site

Browse More Trials